USD 14.8
(2.35%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -17.29 Million EUR | 75.8% |
2022 | -69.17 Million EUR | -5.29% |
2021 | -65.69 Million EUR | -7486.37% |
2020 | -866 Thousand EUR | 97.41% |
2019 | -33.44 Million EUR | -16.41% |
2018 | -28.73 Million EUR | -49.66% |
2017 | -19.19 Million EUR | -64.94% |
2016 | -11.63 Million EUR | -31.98% |
2015 | -8.81 Million EUR | -117.86% |
2014 | -4.04 Million EUR | -115.55% |
2013 | -1.87 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -3.19 Million EUR | 44.53% |
2024 Q1 | -5.75 Million EUR | 75.65% |
2023 Q4 | -23.65 Million EUR | -1071.95% |
2023 FY | -16.73 Million EUR | 75.8% |
2023 Q3 | -2.01 Million EUR | 9.59% |
2023 Q1 | -7.57 Million EUR | 34.04% |
2023 Q2 | -2.23 Million EUR | 70.55% |
2022 Q1 | -19.19 Million EUR | 56.14% |
2022 FY | -69.17 Million EUR | -5.29% |
2022 Q4 | -11.49 Million EUR | 31.21% |
2022 Q3 | -16.7 Million EUR | 23.32% |
2022 Q2 | -21.78 Million EUR | -13.5% |
2021 Q2 | -7.62 Million EUR | -214.79% |
2021 Q4 | -43.76 Million EUR | -267.85% |
2021 Q1 | -2.42 Million EUR | -17.52% |
2021 FY | -65.69 Million EUR | -7486.37% |
2021 Q3 | -11.89 Million EUR | -56.1% |
2020 Q4 | -2.06 Million EUR | -60.06% |
2020 Q2 | 1.97 Million EUR | 288.39% |
2020 Q3 | -1.28 Million EUR | -165.23% |
2020 Q1 | 508 Thousand EUR | 106.27% |
2020 FY | -866 Thousand EUR | 97.41% |
2019 Q2 | -4.98 Million EUR | 62.53% |
2019 FY | -33.44 Million EUR | -16.41% |
2019 Q3 | -7.03 Million EUR | -40.97% |
2019 Q4 | -8.1 Million EUR | -15.29% |
2019 Q1 | -13.31 Million EUR | -43.43% |
2018 Q2 | -5.38 Million EUR | 33.18% |
2018 Q1 | -8.05 Million EUR | 2.1% |
2018 Q3 | -6 Million EUR | -11.55% |
2018 Q4 | -9.28 Million EUR | -54.56% |
2018 FY | -28.73 Million EUR | -49.66% |
2017 Q1 | -4.85 Million EUR | -7.48% |
2017 FY | -19.19 Million EUR | -64.94% |
2017 Q2 | -2.23 Million EUR | 53.91% |
2017 Q3 | -3.87 Million EUR | -73.06% |
2017 Q4 | -8.23 Million EUR | -112.5% |
2016 Q1 | -2.98 Million EUR | 9.15% |
2016 Q4 | -4.51 Million EUR | -104.34% |
2016 Q3 | -2.21 Million EUR | -14.56% |
2016 Q2 | -1.93 Million EUR | 35.23% |
2016 FY | -11.63 Million EUR | -31.98% |
2015 Q1 | -1.49 Million EUR | 0.0% |
2015 FY | -8.81 Million EUR | -117.86% |
2015 Q3 | -2.39 Million EUR | -59.76% |
2015 Q4 | -3.28 Million EUR | -37.01% |
2015 Q2 | -1.49 Million EUR | 0.0% |
2014 FY | -4.04 Million EUR | -115.55% |
2013 FY | -1.87 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alternative Energy Partners, Inc. | -261.11 USD | -6623545.207% |
Allstar Health Brands, Inc. | -215.75 Thousand USD | -7916.222% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | 102.771% |
Café Serendipity Holdings, Inc. | -1.43 Million USD | -1105.148% |
Decision Diagnostics Corp. | - USD | Infinity% |
Health Advance Inc. | -47.57 Thousand USD | -36256.948% |
HealthWarehouse.com, Inc. | -1.62 Million USD | -966.487% |
LIGAND PHARMACEUTICAL INC | 9.82 Million USD | 276.102% |
MedGen, Inc. | -15.54 USD | -111293336.293% |
Omni Health, Inc. | 405.52 Thousand USD | 4364.894% |
Oxford Investments Holdings Inc. | -342.3 Thousand USD | -4952.541% |
Pineapple, Inc. | -1.47 Million USD | -1070.451% |
ScripsAmerica, Inc. | -3.8 Million USD | -354.258% |